Business & Regulation

Nick Armstrong, Senior Director of Digital Enablement at CAI, discusses the realities of digital enablement, artificial intelligence, and more.

Get your pharma heroes nominated by January 12!

Our roundup of some of our thoughtful and inspiring video interviews and roundtables from the past year.

Exploring the gaps and opportunities in Canada’s cell and gene workforce.

Ali Pashazadeh from Treehill Partners offers his advice for navigating the turbulent period and keeping on track for commercial success.

From renewable energy to bicycle schemes and more; here are just a few examples of how a pharma business can be more sustainable.

The details and reactions behind a recent FDA investigation into the cancer-risk of CAR-T therapies

Experts from the Access to Medicine Foundation discuss how to reduce the risk of antimicrobial resistance (AMR) in antibiotic manufacturing.

How do we encourage the development of new cell and gene therapies without compromising our ethics?

Countries that struggled to acquire COVID-19 vaccines have not forgotten the inequity, and are reminding pharma giants that they shouldn’t either